Skip to content

Clinical trials

Completed Neurodegenerative Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Status: Completed Country / region: France Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20082
20092
20101
20112
20121
20131
20141
20151
20162
20171
20183
20195
20203
20213
20226
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics4
Assistance Publique - Hôpitaux de Paris3
Central Hospital, Nancy, France3
LYSOGENE2
Novartis2
Affiris AG1
Alkahest, Inc.1
Alterity Therapeutics1
Amoneta Diagnostics SAS1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases40
Nervous System Diseases11
Alzheimer Disease10
Central Nervous System Diseases8
Dementia8
Brain Diseases7
Cognitive Dysfunction6
Genetic Diseases, Inborn6
Parkinson Disease6
Movement Disorders5

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.